- Home
- RZLT vs FLYX Comparison
RZLT vs FLYX Comparison
Compare RZLT & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- FLYX
- Stock Information
- Founded
- RZLT 2010
- FLYX 2015
- Country
- RZLT United States
- FLYX United States
- Employees
- RZLT N/A
- FLYX N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- RZLT Health Care
- FLYX Finance
- Exchange
- RZLT Nasdaq
- FLYX Nasdaq
- Market Cap
- RZLT 226.4M
- FLYX 264.1M
- IPO Year
- RZLT N/A
- FLYX N/A
- Fundamental
- Price
- RZLT $3.05
- FLYX $3.50
- Analyst Decision
- RZLT Strong Buy
- FLYX
- Analyst Count
- RZLT 8
- FLYX 0
- Target Price
- RZLT $12.00
- FLYX N/A
- AVG Volume (30 Days)
- RZLT 482.0K
- FLYX 23.8K
- Earning Date
- RZLT 05-14-2025
- FLYX 01-01-0001
- Dividend Yield
- RZLT N/A
- FLYX N/A
- EPS Growth
- RZLT N/A
- FLYX N/A
- EPS
- RZLT N/A
- FLYX N/A
- Revenue
- RZLT N/A
- FLYX $311,873,000.00
- Revenue This Year
- RZLT N/A
- FLYX $4.63
- Revenue Next Year
- RZLT N/A
- FLYX $33.97
- P/E Ratio
- RZLT N/A
- FLYX N/A
- Revenue Growth
- RZLT N/A
- FLYX N/A
- 52 Week Low
- RZLT $1.76
- FLYX $1.79
- 52 Week High
- RZLT $6.19
- FLYX $17.82
- Technical
- Relative Strength Index (RSI)
- RZLT 24.55
- FLYX 56.97
- Support Level
- RZLT $3.25
- FLYX $3.00
- Resistance Level
- RZLT $3.81
- FLYX $3.45
- Average True Range (ATR)
- RZLT 0.22
- FLYX 0.27
- MACD
- RZLT -0.05
- FLYX 0.01
- Stochastic Oscillator
- RZLT 4.35
- FLYX 94.96
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.